Targeted therapy for renal cell cancer: current perspectives.

Discovery medicine

Volumn 10, Issue 54, 2010, Pages 394-405

  van der Veldt, Astrid A M ^a   Haanen, John B ^b   van den Eertwegh, Alfons J M ^b   Boven, Epie ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MAMMALIAN TARGET OF RAPAMYCIN; MTOR PROTEIN, HUMAN;

DRUG ANTAGONISM; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; METABOLISM; REVIEW;

ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; TOR SERINE-THREONINE KINASES;

EID: 79952479870     PISSN: None     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Review

References (0)